2017 Pharma Trends Highlights:
- The Good: orphan drugs, developing world sales and continuous manufacturing to push on in 2017
- The Bad: Affordability will remain a concern for sustained revenue growth
- The Donald: The effect his administration will have on the world’s largest pharma economy and the wider implications for the global manufacturing industry is still unclear.
No hay comentarios:
Publicar un comentario